315 related articles for article (PubMed ID: 17412302)
1. Influenza vaccination in systemic lupus erythematosus: safe and protective?
Holvast B; Huckriede A; Kallenberg CG; Bijl M
Autoimmun Rev; 2007 Apr; 6(5):300-5. PubMed ID: 17412302
[TBL] [Abstract][Full Text] [Related]
2. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues.
Abu-Shakra M; Press J; Buskila D; Sukenik S
Autoimmun Rev; 2007 Sep; 6(8):543-6. PubMed ID: 17854746
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
[TBL] [Abstract][Full Text] [Related]
6. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
7. Specific antibody response after influenza immunization in systemic lupus erythematosus.
Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
[TBL] [Abstract][Full Text] [Related]
8. Vaccination and autoimmune rheumatic diseases.
Conti F; Rezai S; Valesini G
Autoimmun Rev; 2008 Dec; 8(2):124-8. PubMed ID: 18700175
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination of patients with systemic lupus erythematosus.
Mercado U; Acosta H; Avendaño L
Rev Invest Clin; 2004; 56(1):16-20. PubMed ID: 15144037
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Stojanovich L
Clin Dev Immunol; 2006; 13(2-4):373-5. PubMed ID: 17162380
[TBL] [Abstract][Full Text] [Related]
12. [Should we vaccinate patients with systemic lupus].
Wiesik-Szewczyk E; Lacki JK; Chwalińiska-Sadowska H
Pol Merkur Lekarski; 2007 Nov; 23(137):395-8. PubMed ID: 18361328
[TBL] [Abstract][Full Text] [Related]
13. Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.
Launay O; Paul S; Servettaz A; Roguet G; Rozenberg F; Lucht F; Lambert C; Presles E; Goulvestre C; Méritet JF; Galtier F; Dubray C; Lebon P; Weill B; Batteux F
Vaccine; 2013 Aug; 31(35):3492-501. PubMed ID: 23764537
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
15. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.
Murdaca G; Orsi A; Spanò F; Puppo F; Durando P; Icardi G; Ansaldi F
Autoimmun Rev; 2014 Feb; 13(2):75-84. PubMed ID: 24044940
[TBL] [Abstract][Full Text] [Related]
16. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
Abu-Shakra M; Zalmanson S; Neumann L; Flusser D; Sukenik S; Buskila D
J Rheumatol; 2000 Jul; 27(7):1681-5. PubMed ID: 10914851
[TBL] [Abstract][Full Text] [Related]
17. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
18. Vaccination in patients with chronic rheumatic or autoimmune diseases.
Glück T; Müller-Ladner U
Clin Infect Dis; 2008 May; 46(9):1459-65. PubMed ID: 18419456
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P
Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089
[TBL] [Abstract][Full Text] [Related]
20. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
